Prevalence of incidental prostate cancer: A systematic review of autopsy studies

Katy J L Bell, Chris Del Mar, Robert Wright, James Dickinson, Paul Glasziou

Research output: Contribution to journalArticleResearchpeer-review

70 Citations (Scopus)

Abstract

Prostate cancer screening may detect nonprogressive cancers, leading to overdiagnosis and overtreatment. The potential for overdiagnosis can be assessed from the reservoir of prostate cancer in autopsy studies that report incidental prostate cancer rates in men who died of other causes. We aimed to estimate the age-specific incidental cancer prevalence from all published autopsy studies. We identified eligible studies by searches of Medline and Embase, forward and backward citation searches and contacting authors. We screened the titles and abstracts of all articles; checked the full-text articles for eligibility and extracted clinical and pathology data using standardized forms. We extracted mean cancer prevalence, age-specific cancer prevalence and validity measures and then pooled data from all studies using logistic regression models with random effects. The 29 studies included in the review dated from 1948 to 2013. Incidental cancer was detected in all populations, with no obvious time trends in prevalence. Prostate cancer prevalence increased with each decade of age, OR=1.7 (1.6-1.8), and was higher in studies that used the Gleason score, OR=2.0 (1.1-3.7). No other factors were significantly predictive. The estimated mean cancer prevalence increased in a nonlinear fashion from 5% (95% CI: 3-8%) at age <30 years to 59% (95% CI: 48-71%) by age >79 years. There was substantial variation between populations in estimated cancer prevalence. There is a substantial reservoir of incidental prostate cancer which increases with age. The high risk of overdiagnosis limits the usefulness of prostate cancer screening.

Original languageEnglish
Pages (from-to)1749-1757
Number of pages9
JournalInternational Journal of Cancer
Volume137
Issue number7
DOIs
Publication statusPublished - 2015

Fingerprint

Autopsy
Prostatic Neoplasms
Neoplasms
Early Detection of Cancer
Logistic Models
Clinical Pathology
Neoplasm Grading
Population
Medical Overuse

Cite this

@article{010e130563004f1690fe7ab43ab960da,
title = "Prevalence of incidental prostate cancer: A systematic review of autopsy studies",
abstract = "Prostate cancer screening may detect nonprogressive cancers, leading to overdiagnosis and overtreatment. The potential for overdiagnosis can be assessed from the reservoir of prostate cancer in autopsy studies that report incidental prostate cancer rates in men who died of other causes. We aimed to estimate the age-specific incidental cancer prevalence from all published autopsy studies. We identified eligible studies by searches of Medline and Embase, forward and backward citation searches and contacting authors. We screened the titles and abstracts of all articles; checked the full-text articles for eligibility and extracted clinical and pathology data using standardized forms. We extracted mean cancer prevalence, age-specific cancer prevalence and validity measures and then pooled data from all studies using logistic regression models with random effects. The 29 studies included in the review dated from 1948 to 2013. Incidental cancer was detected in all populations, with no obvious time trends in prevalence. Prostate cancer prevalence increased with each decade of age, OR=1.7 (1.6-1.8), and was higher in studies that used the Gleason score, OR=2.0 (1.1-3.7). No other factors were significantly predictive. The estimated mean cancer prevalence increased in a nonlinear fashion from 5{\%} (95{\%} CI: 3-8{\%}) at age <30 years to 59{\%} (95{\%} CI: 48-71{\%}) by age >79 years. There was substantial variation between populations in estimated cancer prevalence. There is a substantial reservoir of incidental prostate cancer which increases with age. The high risk of overdiagnosis limits the usefulness of prostate cancer screening.",
author = "Bell, {Katy J L} and {Del Mar}, Chris and Robert Wright and James Dickinson and Paul Glasziou",
note = "{\circledC} 2015 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC.",
year = "2015",
doi = "10.1002/ijc.29538",
language = "English",
volume = "137",
pages = "1749--1757",
journal = "Acta - Unio Internationalis Contra Cancrum",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Prevalence of incidental prostate cancer : A systematic review of autopsy studies. / Bell, Katy J L; Del Mar, Chris; Wright, Robert; Dickinson, James; Glasziou, Paul.

In: International Journal of Cancer, Vol. 137, No. 7, 2015, p. 1749-1757.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Prevalence of incidental prostate cancer

T2 - A systematic review of autopsy studies

AU - Bell, Katy J L

AU - Del Mar, Chris

AU - Wright, Robert

AU - Dickinson, James

AU - Glasziou, Paul

N1 - © 2015 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC.

PY - 2015

Y1 - 2015

N2 - Prostate cancer screening may detect nonprogressive cancers, leading to overdiagnosis and overtreatment. The potential for overdiagnosis can be assessed from the reservoir of prostate cancer in autopsy studies that report incidental prostate cancer rates in men who died of other causes. We aimed to estimate the age-specific incidental cancer prevalence from all published autopsy studies. We identified eligible studies by searches of Medline and Embase, forward and backward citation searches and contacting authors. We screened the titles and abstracts of all articles; checked the full-text articles for eligibility and extracted clinical and pathology data using standardized forms. We extracted mean cancer prevalence, age-specific cancer prevalence and validity measures and then pooled data from all studies using logistic regression models with random effects. The 29 studies included in the review dated from 1948 to 2013. Incidental cancer was detected in all populations, with no obvious time trends in prevalence. Prostate cancer prevalence increased with each decade of age, OR=1.7 (1.6-1.8), and was higher in studies that used the Gleason score, OR=2.0 (1.1-3.7). No other factors were significantly predictive. The estimated mean cancer prevalence increased in a nonlinear fashion from 5% (95% CI: 3-8%) at age <30 years to 59% (95% CI: 48-71%) by age >79 years. There was substantial variation between populations in estimated cancer prevalence. There is a substantial reservoir of incidental prostate cancer which increases with age. The high risk of overdiagnosis limits the usefulness of prostate cancer screening.

AB - Prostate cancer screening may detect nonprogressive cancers, leading to overdiagnosis and overtreatment. The potential for overdiagnosis can be assessed from the reservoir of prostate cancer in autopsy studies that report incidental prostate cancer rates in men who died of other causes. We aimed to estimate the age-specific incidental cancer prevalence from all published autopsy studies. We identified eligible studies by searches of Medline and Embase, forward and backward citation searches and contacting authors. We screened the titles and abstracts of all articles; checked the full-text articles for eligibility and extracted clinical and pathology data using standardized forms. We extracted mean cancer prevalence, age-specific cancer prevalence and validity measures and then pooled data from all studies using logistic regression models with random effects. The 29 studies included in the review dated from 1948 to 2013. Incidental cancer was detected in all populations, with no obvious time trends in prevalence. Prostate cancer prevalence increased with each decade of age, OR=1.7 (1.6-1.8), and was higher in studies that used the Gleason score, OR=2.0 (1.1-3.7). No other factors were significantly predictive. The estimated mean cancer prevalence increased in a nonlinear fashion from 5% (95% CI: 3-8%) at age <30 years to 59% (95% CI: 48-71%) by age >79 years. There was substantial variation between populations in estimated cancer prevalence. There is a substantial reservoir of incidental prostate cancer which increases with age. The high risk of overdiagnosis limits the usefulness of prostate cancer screening.

UR - http://www.scopus.com/inward/record.url?scp=84943379225&partnerID=8YFLogxK

U2 - 10.1002/ijc.29538

DO - 10.1002/ijc.29538

M3 - Article

VL - 137

SP - 1749

EP - 1757

JO - Acta - Unio Internationalis Contra Cancrum

JF - Acta - Unio Internationalis Contra Cancrum

SN - 0020-7136

IS - 7

ER -